JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1990; 16:943-947
© 1990 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giardina, E.
Right arrow Articles by Barr, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giardina, E.
Right arrow Articles by Barr, M.

Myocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantation

EG Giardina, M Schneider, and ML Barr

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032.

Myocardial amiodarone and desethylamiodarone concentrations were measured at multiple sites in the explanted heart in four patients who underwent cardiac transplantation. Patients were taking amiodarone, 200 to 400 mg/day (mean 300 +/- 115), for 88 to 428 days (mean 229 +/- 148). The mean cumulative dose was 58 +/- 21.3 g. Plasma amiodarone concentration in three subjects was 204, 312 and 419 ng/ml and desethylamiodarone concentration was 268, 513 and 880 ng/ml, respectively. Significant interindividual variability in myocardial concentrations of amiodarone and desethylamiodarone was observed (p less than 0.05). Mean myocardial amiodarone concentration ranged from 4 +/- 1.0 to 29 +/- 17.2 micrograms/g (p less than 0.05); mean desethylamiodarone concentration ranged from 22 +/- 8.8 to 141 +/- 102.5 micrograms/g (p less than 0.05). At each site, save for fat, myocardial desethylamiodarone concentration was higher than amiodarone concentration. Greater intraindividual variability was observed in myocardial desethylamiodarone compared with amiodarone concentration particularly in septal and scar tissue (p = NS). No significant relation was found between myocardial concentration and duration of treatment. In patients with significant ventricular disease, usefulness of plasma amiodarone and desethylamiodarone concentration to estimate myocardial concentration is limited by intra- and interindividual variability.


This article has been cited by other articles:


Home page
 CirculationHome page
S. Le Bouter, A. El Harchi, C. Marionneau, C. Bellocq, A. Chambellan, T. van Veen, C. Boixel, B. Gavillet, H. Abriel, K. Le Quang, et al.
Long-Term Amiodarone Administration Remodels Expression of Ion Channel Transcripts in the Mouse Heart
Circulation, November 9, 2004; 110(19): 3028 - 3035.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. J. Connolly
Evidence-Based Analysis of Amiodarone Efficacy and Safety
Circulation, November 9, 1999; 100(19): 2025 - 2034.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Merot, F. Charpentier, J.-M. Poirier, G. Coutris, and J. Weissenburger
Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol
Cardiovasc Res, November 1, 1999; 44(2): 303 - 314.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
X.-J. Du, M. D. Esler, and A. M. Dart
Sympatholytic Action of Intravenous Amiodarone in the Rat Heart
Circulation, January 15, 1995; 91(2): 462 - 470.
[Abstract] [Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1990 by the American College of Cardiology Foundation.